Viewing Study NCT06045260


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-01-25 @ 8:17 AM
Study NCT ID: NCT06045260
Status: RECRUITING
Last Update Posted: 2024-08-13
First Post: 2023-09-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: "Receptor Radionuclide Therapy With 177Lu-DOTATOC
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IRST 100.60
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators